Decline in COPD Admissions During the COVID-19 Pandemic Associated with Lower Burden of Community Respiratory Viral Infections
AuthorSo, Jennifer Y
O'Hara, Nathan N
Williams, John G
deBorja, Christopher L
Slejko, Julia F
Pollak, Andrew N
Reed, Robert M
JournalAmerican Journal of Medicine
MetadataShow full item record
AbstractBackground: The COVID-19 pandemic has led to widespread implementation of public health measures, such as stay-at-home orders, social distancing, and masking mandates. In addition to decreasing spread of SARS-CoV2, these measures also impact the transmission of seasonal viral pathogens, which are common triggers of COPD exacerbations. Whether reduced viral prevalence mediates reduction in COPD exacerbation rates is unknown. Methods: We performed retrospective analysis of data from a large, multicenter healthcare system to assess admission trends associated with community viral prevalence and with initiation of COVID-19 pandemic control measures. We applied difference-in-differences (DiD) analysis to compare season-matched weekly frequency of hospital admissions for COPD before and after implementation of public health measures for COVID-19. Community viral prevalence was estimated using regional Center for Disease Control and Prevention test positivity data and correlated to COPD admissions. Results: Data involving 4,422 COPD admissions demonstrated a season-matched 53% decline in COPD admissions during COVID-19 pandemic, which correlated to community viral burden (r=0.73; 95% CI: 0.67 to 0.78) and represented a 36% greater decline over admission frequencies observed in other medical conditions less affected by respiratory viral infections (IRR, 0.64; 95% CI, 0.57 to 0.71, p<0.001). The post-COVID-19 decline in COPD admissions was most pronounced in patients with fewer comorbidities and without recurrent admissions. Conclusion: The implementation of public health measures during the COVID-19 pandemic was associated with decreased COPD admissions. These changes are plausibly explained by reduced prevalence of seasonal respiratory viruses.
Rights/TermsCopyright © 2021 Elsevier Ltd. All rights reserved.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16043
- Reduction in hospitalised COPD exacerbations during COVID-19: A systematic review and meta-analysis.
- Authors: Alqahtani JS, Oyelade T, Aldhahir AM, Mendes RG, Alghamdi SM, Miravitlles M, Mandal S, Hurst JR
- Issue date: 2021
- Masking for COVID-19 Is Associated with Decreased Emergency Department Utilization for Non-COVID Viral Illnesses and Respiratory Conditions in Maryland.
- Authors: Dezman ZDW, Stryckman B, Zachrison KS, Conrad RM, Marcozzi D, Pimentel L, Samuels-Kalow M, Cairns CB
- Issue date: 2021 Oct
- Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic.
- Authors: Chan KPF, Ma TF, Kwok WC, Leung JKC, Chiang KY, Ho JCM, Lam DCL, Tam TCC, Ip MSM, Ho PL
- Issue date: 2020 Sep
- Reduction in Hospitalizations for Respiratory Diseases during the First COVID-19 Wave in Greece.
- Authors: Kyriakopoulos C, Gogali A, Exarchos K, Potonos D, Tatsis K, Apollonatou V, Loukides S, Papiris S, Sigala I, Katsaounou P, Aggelidis M, Fouka E, Porpodis K, Kontakiotis T, Sampsonas F, Karampitsakos T, Tzouvelekis A, Bibaki E, Karagiannis K, Antoniou K, Tzanakis N, Dimeas I, Daniil Z, Gourgoulianis K, Kouratzi M, Steiropoulos P, Antonakis E, Papanikolaou IC, Ntritsos G, Kostikas K
- Issue date: 2021
- Impact of COVID-19 on Hospital Admissions for COPD Exacerbation: Lessons for Future Care.
- Authors: Lawless M, Burgess M, Bourke S
- Issue date: 2022 Jan 1